We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHPM
4876
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
$8K ﹤0.01%
827
-297
-26% -$2.98K
ORPH
4877
DELISTED
Orphazyme A/S
ORPH
$8K ﹤0.01%
3,425
-10,431
-75% -$36.8K
GSKY
4878
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$8K ﹤0.01%
670
-8,085
-92% -$94.8K
CFV
4879
DELISTED
CF Acquisition Corp. V Class A Common Stock
CFV
$8K ﹤0.01%
802
+681
+563% +$6.73K
SUMR
4880
DELISTED
Summer Infant, Inc.
SUMR
$8K ﹤0.01%
+757
New +$7.43K
PFTAU
4881
DELISTED
Perception Capital Corp. III Unit
PFTAU
$8K ﹤0.01%
841
+110
+15% +$1.1K
CIZN
4882
DELISTED
Citizens Holding Co.
CIZN
$8K ﹤0.01%
398
+163
+69% +$2.99K
RNWK
4883
DELISTED
RealNetworks Inc
RNWK
$8K ﹤0.01%
8,455
-12,482
-60% -$16.2K
AGD
4884
abrdn Global Dynamic Dividend Fund
AGD
$324M
$7K ﹤0.01%
+591
New +$7.08K
AHG
4885
Akso Health Group
AHG
$1.26B
$7K ﹤0.01%
+4,435
New +$16.4K
AMWD
4886
DELISTED
American Woodmark
AMWD
$7K ﹤0.01%
100
-2,216
-96% -$150K
AQST icon
4887
Aquestive Therapeutics
AQST
$533M
$7K ﹤0.01%
+1,788
New +$8.97K
ARKX icon
4888
ARK Space & Defense Innovation ETF
ARKX
$864M
$7K ﹤0.01%
+381
New +$7.51K
AUUD
4889
Auddia
AUUD
$5.47M
$7K ﹤0.01%
1
AVPT icon
4890
AvePoint
AVPT
$2.91B
$7K ﹤0.01%
1,144
-16,179
-93% -$125K
BH.A icon
4891
Biglari Holdings Class A
BH.A
$1.23B
$7K ﹤0.01%
+10
New +$7.55K
BURU
4892
DELISTED
NUBURU INC
BURU
$7K ﹤0.01%
+4
New +$7.85K
CABA icon
4893
Cabaletta Bio
CABA
$442M
$7K ﹤0.01%
1,797
+355
+25% +$3.79K
CANG
4894
Cango Inc
CANG
$92.7M
$7K ﹤0.01%
215
-854
-80% -$32.3K
CBAN icon
4895
Colony Bankcorp
CBAN
$467M
$7K ﹤0.01%
+415
New +$7.54K
CCLD icon
4896
CareCloud
CCLD
$104M
$7K ﹤0.01%
1,053
-5,700
-84% -$40.4K
CLRO icon
4897
ClearOne Inc
CLRO
$15.2M
$7K ﹤0.01%
347
+212
+157% +$5.08K
CMT icon
4898
Core Molding Technologies
CMT
$224M
$7K ﹤0.01%
844
+256
+44% +$2.56K
COCH icon
4899
Envoy Medical
COCH
$57.6M
$7K ﹤0.01%
+694
New +$6.77K
COHN icon
4900
Cohen & Co
COHN
$38.7M
$7K ﹤0.01%
468
-9
-2% -$161

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.